−0.0074USD
−3.10 MUSD
557.71 KUSD
385.53 M
About Provectus Biopharmaceuticals, Inc.
Sector
Industry
CEO
Edward V. Pershing
Website
Headquarters
Knoxville
Employees (FY)
4
Founded
2002
ISIN
US74373P1084
FIGI
BBG000PGR5K3
Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter in 2002 and is headquartered in Knoxville, TN.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PVCT is 0.1900 USD — it has decreased by 2.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Provectus Biopharmaceuticals, Inc. stocks are traded under the ticker PVCT.
Provectus Biopharmaceuticals, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
PVCT stock is 8.33% volatile and has beta coefficient of 2.35. Check out the list of the most volatile stocks — is Provectus Biopharmaceuticals, Inc. there?
Yes, you can track Provectus Biopharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
PVCT stock has risen by 4.40% compared to the previous week, the month change is a 4.95% fall, over the last year Provectus Biopharmaceuticals, Inc. has showed a 30.09% increase.
PVCT net income for the last quarter is −663.41 K USD, while the quarter before that showed −775.84 K USD of net income which accounts for 14.49% change. Track more Provectus Biopharmaceuticals, Inc. financial stats to get the full picture.
Today Provectus Biopharmaceuticals, Inc. has the market capitalization of 81.81 M, it has decreased by 17.20% over the last week.
No, PVCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PVCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Provectus Biopharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 4.00 employees. See our rating of the largest employees — is Provectus Biopharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Provectus Biopharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Provectus Biopharmaceuticals, Inc. stock shows the buy signal. See more of Provectus Biopharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Provectus Biopharmaceuticals, Inc. EBITDA is −2.87 M USD, and current EBITDA margin is −522.95%. See more stats in Provectus Biopharmaceuticals, Inc. financial statements.